Dr Nigel Rogers was formerly Director of Pre-clinical Science at Roche Discovery Welwyn and was instrumental in introducing new early ADMET approaches to enable better selection and design of compounds in Lead Optimisation.
Nigel has also extensive experience of the process from Lead Identification through to NDA filing with responsibilities including project management, regulatory affairs and leadership of several projects. Nigel began his career at Roche as a Medicinal Chemist and continues to have a strong interest in the relationship of chemical structure to ADMET properties.
He is now an independent consultant providing advice to the Pharma Industry.








